White label ELPA - ClinicalTrials.eu

Study on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome

Not recruiting

3 1
Investigated Diseases:
- Familial hypertriglyceridaemia
Investigated Drugs:
- Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
+1
Study on the Effects of Losartan Potassium on Brain Tumors in Patients with Glioblastoma or Brain Metastases from Non-Small-Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Metastases to central nervous system
- Glioblastoma
Investigated Drugs:
- Losartan Potassium
Study on Sonoporation-Enhanced Treatment with Gemcitabine, Nab-Paclitaxel, and FOLFIRINOX for Patients with Inoperable Pancreatic Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Pancreatic carcinoma
Investigated Drugs:
Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Safety of Radiation and Nivolumab for Patients with Esophageal Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Oesophageal carcinoma
Investigated Drugs:
- Nivolumab
Study on Tocotrienol and Bevacizumab for Patients with Metastatic Colorectal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
Study on Psilocybin for Patients with Treatment-Resistant Depression

Not recruiting

2 1 1
Investigated Diseases:
- Depression
Investigated Drugs:
- Psilocybine
Study on Personalized Treatment for Metastatic Colorectal Cancer Using Regorafenib for Patients with Advanced Disease

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
- Regorafenib
Study on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis

Not recruiting

2 1
Investigated Drugs:
- Obexelimab
+4
Study of Vusolimogene Oderparepvec and Nivolumab for Patients with Solid Tumors

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Vusolimogene Oderparepvec
- Nivolumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies